Empiric therapy for endocarditis commonly includes which combination?

Empiric therapy for endocarditis commonly includes which combination?

• A. Ceftriaxone + Ampicillin
• B. Vancomycin alone
• C. Vancomycin + Ceftriaxone
• D. Linezolid + Doxycycline

Answer: (C)

Empiric endocarditis therapy is about broadly covering the most likely organisms until culture results identify the culprit. The goal is to hit both resistant Gram-positive organisms and the usual Gram-positive cocci, as well as Gram-negative and fastidious pathogens that can cause endocarditis. Vancomycin provides reliable activity against MRSA and many other Gram-positive cocci, including many enterococci. Ceftriaxone is a third-generation cephalosporin that effectively covers viridans group streptococci and a wide range of Gram-negative organisms, including the HACEK group of fastidious bacteria often implicated in endocarditis. Together, they deliver broad coverage for the common causative organisms of endocarditis when the exact pathogen isn’t yet known, and they can be adjusted once culture data come back. The other regimens fall short: vancomycin alone misses Gram-negative pathogens; ceftriaxone alone misses MRSA; and a linezolid plus doxycycline combination lacks reliable bactericidal activity and doesn’t provide optimal coverage for all typical endocarditis pathogens.

Empiric endocarditis therapy is about broadly covering the most likely organisms until culture results identify the culprit. The goal is to hit both resistant Gram-positive organisms and the usual Gram-positive cocci, as well as Gram-negative and fastidious pathogens that can cause endocarditis.

Vancomycin provides reliable activity against MRSA and many other Gram-positive cocci, including many enterococci. Ceftriaxone is a third-generation cephalosporin that effectively covers viridans group streptococci and a wide range of Gram-negative organisms, including the HACEK group of fastidious bacteria often implicated in endocarditis. Together, they deliver broad coverage for the common causative organisms of endocarditis when the exact pathogen isn’t yet known, and they can be adjusted once culture data come back.

The other regimens fall short: vancomycin alone misses Gram-negative pathogens; ceftriaxone alone misses MRSA; and a linezolid plus doxycycline combination lacks reliable bactericidal activity and doesn’t provide optimal coverage for all typical endocarditis pathogens.